FR940721-1-00087 FR940721-1-00015 3. Section 862.2310 is amended by revising paragraph (b) to read as follows: §862.2310 Clinical sample concentrator. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter only when the products are intended for general use, make no specific claims, and only if labeling follows the format in §809.10 of this chapter. 4. Section 862.2320 is amended by revising paragraph (b) to read as follows: §862.2320 Beta and gamma counter for clinical use. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter only when the products are intended for general use, make no specific claims, and only if labeling follows the format in §809.10 of this chapter. 5. Section 862.2485 is amended by revising paragraph (b) to read as follows: §862.2485 Electrophoresis apparatus for clinical use. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter only when the products are intended for general use, make no specific claims, and only if labeling follows the format in §809.10 of this chapter. 6. Section 862.2720 is amended by revising paragraph (b) to read as follows: §862.2720 Plasma oncometer for clinical use. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter only when the products are intended for general use, make no specific claims, and only if labeling follows the format in §809.10 of this chapter. 7. Section 862.2800 is amended by revising paragraph (b) to read as follows: §862.2800 Refractometer for clinical use. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter only when the products are intended for general use, make no specific claims, and only if labeling follows the format in §809.10 of this chapter. 8. Section 862.2920 is amended by revising paragraph (b) to read as follows: §862.2920 Plasma viscometer for clinical use. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter only when the products are intended for general use, make no specific claims, and only if labeling follows the format in §809.10 of this chapter. PART 864_HEMATOLOGY AND PATHOLOGY DEVICES 9. The authority citation for 21 CFR part 864 continues to read as follows: Authority: Secs. 501, 510, 513, 515, 520, 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351, 360, 360c, 360e, 360j, 371). 10. Section 864.2280 is amended by revising paragraph (b) to read as follows: §864.2280 Cultured animal and human cells. * * * * * (b) Classification. Class I. The devices are exempt from the premarket notification procedures in subpart E of part 807 of this chapter. 11. Section 864.5350 is amended by revising paragraph (b) to read as follows: §864.5350 Microsedimentation centrifuge. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter. 12. Section 864.7660 is amended by revising paragraph (b) to read as follows: §864.7660 Leukocyte alkaline phosphatase test. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter. 13. Section 864.7675 is amended by revising paragraph (b) to read as follows: §864.7675 Leukocyte peroxidase test. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter. 14. Section 864.7900 is amended by revising paragraph (b) to read as follows: §864.7900 Thromboplastin generation test. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter. 15. Section 864.8500 is amended by revising paragraph (b) to read as follows: §864.8500 Lymphocyte separation medium. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter. PART 866_IMMUNOLOGY AND MICROBIOLOGY DEVICES 16. The authority citation for 21 CFR part 866 continues to read as follows: Authority: Secs. 501, 510, 513, 515, 520, 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351, 360, 360c, 360e, 360j, 371). 17. Section 866.5170 is amended by revising paragraph (b) to read as follows: §866.5170 Breast milk immunological test system. * * * * * (b) Classification. Class I. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter.
